Alendronate treatment in men with primary osteoporosis: A three-year longitudinal study

Calcified Tissue International

Volumn 73, Issue 2, 2003, Pages 133-139

  Gonnelli, S ^a   Cepollaro, C ^a   Montagnani, A ^a   Bruni, D ^a   Caffarelli, C ^a   Breschi, M ^a   Gennari, L ^a   Gennari, C ^a   Nuti, R ^a  

^a NONE

Author keywords

Alendronate; Bone mineral density; Male osteoporosis; Quantitative ultrasound

Indexed keywords

ALENDRONIC ACID; BISPHOSPHONIC ACID DERIVATIVE; CALCIUM;

ADULT; AGED; ARTICLE; BONE DENSITY; BONE MASS; BONE MINERAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; DRUG UTILIZATION; DUAL ENERGY X RAY ABSORPTIOMETRY; ECHOGRAPHY; EVALUATION; FEMUR NECK; HIP; HUMAN; LONG TERM CARE; LONGITUDINAL STUDY; LUMBAR SPINE; MAJOR CLINICAL STUDY; MALE; PARAMETER; PRIMARY OSTEOPOROSIS; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RANDOMIZED CONTROLLED TRIAL; SENSITIVITY ANALYSIS; TECHNIQUE;

EID: 0041335546     PISSN: 0171967X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00223-002-1085-7     Document Type: Article

References (33)

1. Melton III LJ (2001) The prevalence of osteoporosis: gender and racial comparison. Calcif Tissue Int 69:179-181
2. Seeman E (1999) Osteoporosis in men. Osteoporos Int (suppl) 2:S97-S110
3. Cooper C, Campion G, Melton III LJ (1992) Hip fractures in the elderly: a world-wide projection. Osteoporos Int 2:285-289
4. Orwoll ES (1998) Osteoporosis in men. Osteoporos Int 27:349-367
5. O'Neill TW, Felsenberg D, Varlow J, Cooper C, Kanis JA, Silman AJ (1996) The prevalence of vertebral deformity in European men and women: The European Vertebral Osteoporosis Study. J Bone Miner Res 11:1010-1018
6. Center JR, Nguyen TV, Schneider D, Sambrook PN, Eisman JA (1999) Mortality after all major types of osteoporotic fracture in men and women: an observational study. Lancet 353:878-882
7. Katznelson L, Finkelstein JS, Schoenfeld DA, Rosenthal EJ, Anderson EJ, Klibanski A (1996) Increase in bone density and lean body mass during testosterone administration in men with acquired hypogonadism. J Clin Endocrinol Metab 12:43-58
8. Snyder PJ, Peachey H, Berlin JA, Hannoush P, Hadda G, Dlewati A, Santanna J, Loh I, Lenrow DA, Olmes JH, Kapoor SC, Atkinson LE, Strom BL (1999) Effect of testosterone replacement in hypogonadal men. J Clin Endocrinol Metab 84:1966-1972
9. Orwoll E, Ettinger M, Weiss S, Miller P, Kendler D, Graham J, Adami S, Weber K, Lorene R, Pietschmann P, Vandormaci K, Lombardi A (2000) Alendronate for the treatment of osteoporosis in men. N Engl J Med 343:604-610
10. Ho YV, Frauman AG, Thomson W, Seeman E (2000) Effects of alendronate on bone density in men with primary and secondary osteoporosis. Osteoporos Int 11:98-101
11. Ringe JD, Faber H, Dorst A (2001) Alendronate treatment of established primary osteoporosis in men: results of a two-year prospective study. J Clin Endocrinol Metab 86:5252-5255
12. Weber T, Drezner M (2001) Effect of alendronate on bone mineral density in male idiopathic osteoporosis. Metabolism 50:912-915
13. Liberman UA, Weiss SR, Broll J, Minnie HW, Quan H, Bell NH, Rodriguez-Portales J, Downs Jr RW, Dequecker M, Favus M (1995) Effect of oral alendronate on bone mineral density and the incidence of fractures in post-menopausal osteoporosis. N Engl J Med 333:1437-1443
14. Black DM, Cummings SR, Karpf DB, Cauley JA, Thompson DE, Nevitt MC, Bauer DC, Genant HK, Haskell WL, Marcus R, Ott SM, Torner JC, Quandt SA, Reiss TF, Ensrud KE for the Fracture Intervention Trial Research Group (1996) Randomized trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Lancet 348:1535-1541
15. Cortet B, Dubois P, Boutry N, Palos G, Cotton A, Marchandise X (2002) Computed tomography image analysis of the calcaneous in male osteoporosis. Osteoporos Int 13:33-41
16. Legrand E, Chappard D, Pascaretti C, Duquenne M, Rondeau C, Simon Y, Rohmer V, Basle MF, Audran M (1999) Bone mineral density and vertebral fractures in men. Osteoporos Int 10:265-270
17. Gluer CC, for the International Quantitative Ultrasound Consensus Group (1997) Quantitative ultrasound techniques for the assessment of osteoporosis: expert agreement on current status. J Bone Miner Res 12:1280-1288
18. Gluer CC, Wu CY, Jergas M, Goldstein SA, Genant HK (1994) Three quantitative ultrasound parameters reflect bone structure. Calcif Tissue Int 55:46-52
19. Njeh CF, Fuerst T, Diessel E, Genant HK (2001) Is quantitative ultrasound dependent on bone structure'? A reflection. Osteoporos Int 12:1-15
20. Hans D, Dargent-Molina P, Schott AM, Sebert JL, Cormier C, Kotzki PO, Delmas PD, Pouilles JM, Breart G, Meunier PG for the EPIDOS prospective study group (1996) Ultrasonographic heel measurements to predict hip fracture in elderly women: the EPIDOS prospective study. Lancet 348:511-514
21. Bauer DC, Gluer CC, Cauley JA, Vogt TM, Ensrud KE, Genant HK, Blake DM for the study of osteoporotic fractures research group (1997) Broadband ultrasound attenuation predicts fractures strongly and independently of densitometry in older women. Arch Intern Med 157:629-634
22. Sahota O, San P, Cawte SA, Pearson D, Hosking DJ (2000) A comparison of the longitudinal changes in quantitative ultrasound with dual-energy X-ray absorptiometry: the four-year effects of hormone replacement therapy. Osteoporos Int 11:52-58
23. Gonnelli S, Cepollaro C, Montagnani A, Martini S, Gennari L, Mangeri M, Gennari C (2002) Heel ultrasonography in monitoring alendronate therapy: a four-year longitudinal study. Osteoporos Int 13:415-421
24. Krieg MA, Jacquet AF, Bremgartner M, Cuttelod S, Thiebaud D, Burckardt P (1999) Effect of supplementation with vitamin D3 and calcium on quantitative ultrasound of bone in elderly institutionalized women: a longitudinal study. Osteoporos Int 9:483-488
25. Pluskiewicz W, Drozdzowska B (1999) Ultrasound measurements at the calcaneus in men: differences between healthy and fractured persons and the influence of age and anthropometric features on ultrasound parameters. Osteoporos Int 10:47-51
26. Adler RA, Funkhouser HL, Holt CM (2001) Utility of heel ultrasound bone density in men. J Clin Densitom 3:225-230
27. Montagnani A, Gonnelli S, Cepollaro C, Mangeri M, Monaco R, Gennari L, Gennari C (2001) Usefulness of bone quantitative ultrasound in management of osteoporosis in men. J Clin Densitom 3:231-237
28. Mulleman D, Legroux-Gerot I, Duquesnoy B, Marchandies X, Delcambre B, Cortet B (2002) Quantitative ultrasound in bone male osteoporosis. Osteoporos Int 13:388-393
29. Gluer CC (1999) Monitoring skeletal changes by radiological techniques. J Bone Miner Res 14:1952-1962
30. Tucci JR, Tonino RP, Emkey RD, Peverly CA, Kher U, Santora II AC for the U.S. Alendronate Phase III Osteoporosis Treatment Study Group (1996) Effect of three years of oral alendronate treatment in postmenopausal women with osteoporosis. Am J Med 101:488-501
31. Parfitt AM (1980) Morphologic basis of bone mineral measurements: transient and steady state effects of treatment in osteoporosis. Miner Electrolyte Metab 4:273-287
32. Hanson J (1997) Standardization of femur BMD (letter). J Bone Miner Res 12:1316-1317
33. Patel R, Blake GM, Rymer J, Fogelman I (2000) Long-term precision of DXA scanning assessed over seven years in forty postmenopausal women. Osteoporos Int 11:68-75